Overexpression of bcl-2 attenuates mpp+, but not 6-odha, induced cell death in a dopaminergic neuronal cell line

Young J. Oh, Shou C. Wong, Mark Moffat, Karen L. O’Malley

Research output: Contribution to journalArticle

50 Citations (Scopus)


In order to investigate the role of Bcl-2 in dopaminergic cells, we established a dopaminergic neuronal cell line (MN9D) stably expressing human Bcl-2 (MN9D/Bcl-2) or neomycin (MN9D/Neo). Overexpression of Bcl-2 in MN9D cells attenuated cell death due to treatment of mitochondrial electron transport inhibitors including N-methyl-4-phenylpyridinium, whereas it did not prevent cell death induced by reagents generating reactive oxygen species including 6-hydroxy-dopamine. Moreover, the rate of glucose uptake in MN9D/Bcl-2 was significantly lower than that in MN9D/Neo after MPP+ treatment. Thus, Bcl-2 may counter aberrations in mitochondrial electron transfer processes by altering energy metabolism within the MN9D cells.

Original languageEnglish
Pages (from-to)157-167
Number of pages11
JournalNeurobiology of Disease
Issue number3
Publication statusPublished - 1995 Jan 1


All Science Journal Classification (ASJC) codes

  • Neurology

Cite this